EGFR inhibitors-related panniculitis: A new side effect
Epidermal growth factor receptor (EGFR) inhibitors are widely used in the treatment of advanced malignancies, and their skin toxicity is frequent and well recognized in the literature. We report the case of a 69-year-old patient with a history of adenocarcinoma of the lung treated with several EGFR...
Main Authors: | Sofia Lopes, Ana Nogueira, Joana Pardal, Filomena Azevedo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Dermatology Online Journal |
Subjects: | |
Online Access: | http://www.idoj.in/article.asp?issn=2229-5178;year=2019;volume=10;issue=3;spage=319;epage=321;aulast=Lopes |
Similar Items
-
Delayed-onset vemurafenib-induced panniculitis
by: Stephen L. Vance, MD, MBA, et al.
Published: (2017-09-01) -
Lupus panniculitis: diagnostic difficulties
by: O. N. Egorova, et al.
Published: (2019-09-01) -
Septal panniculitis: Clinico-pathological review of the literature and case presentation
by: Gabriela Martinez Braga, et al.
Published: (2014-01-01) -
Cutaneous T-cell lymphoma presenting as panniculitis with arthritis
by: Rasmi Ranjan Sahoo, et al.
Published: (2017-01-01) -
Panniculitis: rheumatological aspects
by: O. N. Egorova, et al.
Published: (2018-06-01)